Immuneering Corporation Class A Share Price
NASDAQ: IMRX | Micro CapImmuneering Corporation Class A Stock Performance
Immuneering Corporation Class A Share Price Today
As of 19 September 2026, Immuneering Corporation Class A's share price is $4.46. The stock opened at $4.49, compared to its previous close of $4.47. During today's trading session, Immuneering Corporation Class A's share price traded between $4.42 and $4.49, with an average price of $4.45. Over the past 52 weeks, the stock has recorded a high of $10.04 and a low of $3.90. In terms of performance, Immuneering Corporation Class A's share price has declined by 15.30% over the last six months and is down 36.13% on a year-on-year basis.
Immuneering Corporation Class A Share Price Chart
About Immuneering Corporation Class A
Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
Immuneering Corporation Class A Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $4.92 | $4.46 | -14.74% |
Aug 2026 | $4.13 | $5.22 | +26.51% |
Jul 2026 | $5.10 | $4.13 | -17.23% |
Jun 2026 | $5.65 | $4.99 | -13.67% |
May 2026 | $5.21 | $5.78 | +9.99% |
Apr 2026 | $5.29 | $5.25 | -0.10% |
Mar 2026 | $4.86 | $5.26 | +4.99% |
Feb 2026 | $4.62 | $5.01 | +8.09% |
Jan 2026 | $6.53 | $4.63 | -29.45% |
Dec 2025 | $7.47 | $6.57 | -14.34% |
Nov 2025 | $6.75 | $7.67 | +11.56% |
Oct 2025 | $6.93 | $6.88 | -1.43% |